SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001175707-23-000084
Filing Date
2023-02-14
Accepted
2023-02-14 15:23:55
Documents
1

Document Format Files

Seq Description Document Type Size
1 13ga1_sarepta.htm SC 13G/A 73372
  Complete submission text file 0001175707-23-000084.txt   75554
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Subject) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-54847 | Film No.: 23627875
SIC: 2834 Pharmaceutical Preparations

Mailing Address SANDS CAPITAL MANAGEMENT, LLC 1000 WILSON BLVD, SUITE 3000 ARLINGTON VA 22209
Business Address SANDS CAPITAL MANAGEMENT, LLC 1000 WILSON BLVD, SUITE 3000 ARLINGTON VA 22209 703-562-4000
SANDS CAPITAL MANAGEMENT, LLC (Filed by) CIK: 0001020066 (see all company filings)

IRS No.: 202830751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A